Yahoo
Swiss - Delayed Quote CHF

Basilea Pharmaceutica AG (BSLN.SW)

70.80 -0.70 (-0.98%)
At close: October 30 at 5:30:30 PM GMT+1
View in AlphaSpace Currency in CHF All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
247,416
232,380
208,543
157,634
147,765
Cost of Revenue
30,522
39,323
38,681
26,794
24,603
Gross Profit
216,894
193,057
169,862
130,840
123,162
Operating Expense
157,800
141,511
108,685
111,635
104,619
Operating Income
59,094
51,546
61,177
19,205
18,543
Net Non Operating Interest Income Expense
-1,509
-2,087
-2,928
-9,512
-9,522
Pretax Income
58,676
45,875
60,260
10,461
12,102
Tax Provision
6,292
5,635
-17,333
10
-45
Net Income Common Stockholders
52,384
40,240
77,593
10,451
12,147
Average Dilution Earnings
--
2,760
3,107
--
--
Diluted NI Available to Com Stockholders
55,144
43,000
80,700
10,451
12,147
Basic EPS
4.26
3.29
6.42
0.87
1.02
Diluted EPS
4.01
3.14
5.83
0.86
1.02
Basic Average Shares
12,305.16
12,240.60
12,089.67
11,991.39
11,860.96
Diluted Average Shares
13,665.59
13,684.71
13,855.04
12,143.08
11,943.53
Total Operating Income as Reported
59,094
51,546
61,177
19,205
18,543
Total Expenses
188,322
180,834
147,366
138,429
129,222
Net Income from Continuing & Discontinued Operation
52,384
40,240
77,593
10,451
12,147
Normalized Income
52,384
40,240
77,593
10,451
12,147
Interest Income
1,332
1,270
1,416
1,690
326
Interest Expense
2,841
3,357
4,344
11,202
9,848
Net Interest Income
-1,509
-2,087
-2,928
-9,512
-9,522
EBIT
61,517
49,232
64,604
21,663
21,950
EBITDA
63,360
51,046
66,336
23,240
23,047
Reconciled Cost of Revenue
30,522
39,323
38,681
26,794
24,603
Reconciled Depreciation
1,843
1,814
1,732
1,577
1,097
Net Income from Continuing Operation Net Minority Interest
52,384
40,240
77,593
10,451
12,147
Total Unusual Items Excluding Goodwill
--
--
--
--
-41
Total Unusual Items
--
--
--
--
-41
Normalized EBITDA
63,360
51,046
66,336
23,240
23,047
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 3/25/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: